Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q3 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
AXDX on Nasdaq
Shares outstanding
25,224,523
Price per share
$0.13
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-100
Value change
-$1
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 7.4% -10% $1,317,338 -$139,340 1,879,227 -9.6% Armistice Capital, LLC 31 Mar 2025
GRIFFIN ASSET MANAGEMENT, INC. 4% $703,510 1,003,581 Griffin Asset Management, LLC 31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDX). This represents 0% of the company’s total 25,224,523 outstanding shares.

Institutional Holders of Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$1 $0.13 0
2025 Q2 100 $1 -$2,875,620 $0.01 1
2025 Q1 4,106,069 $2,875,905 -$238,367 $0.70 41
2024 Q4 4,357,049 $5,227,126 -$105,085 $1.20 42
2024 Q3 4,469,210 $7,642,787 +$938,755 $1.71 42
2024 Q2 3,927,856 $4,595,026 -$378,311 $1.17 41
2024 Q1 4,276,315 $4,231,914 +$1,973,563 $0.99 44
2023 Q4 2,201,634 $8,630,604 -$470,241 $3.92 40
2023 Q3 2,261,996 $13,006,914 +$12,143,347 $5.75 35
2023 Q2 205,042 $166,325 +$166,327 $0.81 2